Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
83.50    0.00 (0.00%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £11.17m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Preliminary Results

3 Aug 2012 07:00

RNS Number : 2143J
Arcontech Group PLC
03 August 2012
 



ARCONTECH GROUP PLC

 

("Arcontech" or the "Company")

 

PRELIMINARY RESULTS FOR THE YEAR ENDED 30 JUNE 2012

 

Arcontech Group plc (AIM: ARC), a provider of enterprise level real-time software solutions to the investment banking and broking sectors, reports its preliminary results for the year ended 30 June 2012.

 

Chairman's Statement

 

Arcontech Group plc has achieved notable progress during the year ended 30 June 2012. The business is now focused on the CityVision suite of software products with particular emphasis on Multi Vendor Contribution Systems ("MVCS"), Excelerator, our real time Excel product and CityVision Cache.

 

We believe that the opportunities for our products are at a level not previously experienced by the group. We do, however, have to convert these opportunities into sales. Whilst this has proved a little frustrating, with decision-making and proof of concept trials taking longer, we have secured new contracts of almost £1 million over three years. As at 30 June 2012 the contracted annual recurring licence fees amounted to £1,589,110 (2011: £1,538,216) representing approximately 76% of our annual costs (2011: 73%).

 

Turnover for the year increased by 14% to £1,463,530 (2011: £1,287,409). The underlying increase was 28% after eliminating revenue from the loss-making AXE product, which we stopped actively marketing during the year. The operating loss for the year was £595,147 (2011: £817,855). During the year we continued to invest significantly in product development and improvement. These costs are written off as they are incurred.

 

Financing

 

As at 30 June 2012 Arcontech had cash balances of £746,675 (2011: £841,204). The reduction in our cash resources is due to the operating loss incurred during the year, arising primarily due to our continued investment in product development together with lengthening payment periods from clients. Based upon the level of our sales prospects and our continued tight control of costs the Board believes that Arcontech has sufficient financial resources to see the business through to profitability.

 

Employees

 

As in previous years I should like to thank our employees for their continued hard work, dedication and support over the last twelve months. Working in a small business often requires employees to be extremely flexible and understanding, this is greatly appreciated.

 

Outlook

 

With the level of sales prospects that Arcontech presently has we are hopeful of making significant progress towards breakeven in the coming year. It remains, however, difficult to determine the precise timing of future contracts, as sales cycles remain protracted. To help improve our chances of success we are looking to increase our sales resource in the coming months.

 

Richard Last

Chairman

 

2 August 2012

 

 

Chief Executive's Review

 

I am pleased with the progress made this year with the enhancement and rationalisation of the CityVision product suite. CityVision now addresses several areas of current demand in a more appropriate and immediately deployable manner and we are seeing strong interest, evidenced by increased sales, from both new and existing clients.

 

The uptake of the redesigned 'Excelerator' product, which provides a vendor-neutral means of publishing and receiving real-time market data into Microsoft Excel, has increased significantly. Excelerator's ability to integrate with, and provide a migration path between, Thomson Reuters and Bloomberg is a compelling value proposition amongst investment banks eager to reduce costs and reduce lock-in to particular vendors.

 

CityVision Cache, a new product development this year, gives customers increased choice of technology and is also attracting strong interest, with recent new sales.

 

New contracts have been longer in negotiation than I would have liked, impairing our revenue growth. Nonetheless, the number of ongoing and successful product evaluations and prospects at or close to contract stage support optimism over forward revenues.

 

Interest from outside the UK and, in particular, new sales activity in the Nordic regions continues and we have seen several of the new contracts anticipated in last year's review. We have further refined our offerings for integration with Thomson Reuters and Bloomberg and the new product developments mentioned last year are now deployed with Tier 1 and Tier 2 investments banks, facilitating considerable cost reductions and future flexibility.

 

Increased sales and marketing activity, resulting in significant product interest, has demanded additional pre and post sales resource to support trials and product roll-out. We have recruited in response to this demand and our expanded, experienced support team is well equipped to deal with forecast new business.

 

Some notable points for the year have been:

 

·; Successful live deployment of CityVision in multiple regions

·; New contracts for Excelerator, MVCS and CityVision Cache

·; Upgrade of several clients to the enhanced product set

·; 100% retention of existing CityVision clients

·; Increase in contracted recurring revenues of approximately £1 million

 

Our status as an independent software supplier, with two-way interfaces between the popular vendors, positions us well to take advantage of the prevailing demand for customer choice of data vendor and delivery technology.

 

I would like to thank the board, our staff and particularly our new and existing clients for their continued support and look forward to further successes in the coming year.

 

Andrew Miller

Chief Executive

 

 

Enquiries:

 

Arcontech Group plc

 

Andrew Miller, Chief Executive

 

Sarah Wisbey

+44 20 7256 2300

 

 

Northland Capital Partners Limited

 

Shane Gallwey

+44 20 7796 8823

 

 

Group Income Statement

 

For the year ended 30 June 2012

 

 

 

2012

 

2011

 

£

 

£

 

 

 

 

Revenue

1,463,530

 

1,287,409

 

 

 

 

Distribution costs

(19,477)

 

(16,428)

 

 

 

 

Administrative costs

(2,039,200)

 

(2,088,836)

 

Operating loss

(595,147)

 

(817,855)

 

 

 

 

Finance income

8,756

 

13,134

 

Loss before taxation

(586,391)

 

(804,721)

 

 

 

 

Taxation

85,319

 

132,683

 

Loss for the year after tax

(501,072)

 

(672,038)

 

Total comprehensive income

(501,072)

 

(672,038)

 

Loss per share (basic and diluted)

(0.03)p

 

(0.04)p

 

All of the results relate to continuing operations.

 

 

Statement of Changes in Equity

 

For the year ended 30 June 2012

 

Group:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

 

£

£

£

£

£

Balance at 1 July 2010

1,531,315

9,428,169

143,297

(8,300,747)

2,802,034

 

 

 

 

 

 

Loss for the year

-

-

-

(672,038)

(672,038)

 

Total comprehensive income for the year

-

-

-

(672,038)

(672,038)

 

 

 

 

 

 

Share-based payments

-

-

2,241

-

2,241

 

 

 

 

 

 

 

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(8,972,785)

2,132,237

 

 

 

 

 

 

Loss for the year

-

-

-

(501,072)

(501,072)

 

Total comprehensive income for the year

-

-

-

(501,072)

(501,072)

 

 

 

 

 

 

Share-based payments

-

-

45,222

-

45,222

 

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(9,473,857)

1,676,387

 

Company:

 

Share

capital

Share

premium

Share option reserve

Retained

earnings

Total

equity

 

£

£

£

£

£

Balance at 1 July 2010

1,531,315

9,428,169

143,297

(7,447,378)

3,655,403

 

 

 

 

 

 

Loss for the year

-

-

-

(82,460)

(82,460)

 

Total comprehensive income for the year

-

-

-

(82,460)

(82,460)

 

 

 

 

 

 

Share-based payments

-

-

2,241

-

2,241

 

 

 

 

 

 

 

Balance at 30 June 2011

1,531,315

9,428,169

145,538

(7,529,838)

3,575,184

 

 

 

 

 

 

Loss for the year

-

-

-

(35,850)

(35,850)

 

Total comprehensive income for the year

-

-

-

(35,850)

(35,850)

 

 

 

 

 

 

Share-based payments

-

-

45,222

-

45,222

 

Balance at 30 June 2012

1,531,315

9,428,169

190,760

(7,565,688)

3,584,556

 

 

Balance Sheets

 

As at 30 June 2012

 

 

Group2012£

 

Group2011£

 

Company2012£

 

Company2011

£

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

1,715,153

 

1,715,153

 

-

 

-

 

 

 

 

 

 

 

 

Property, plant and equipment

34,263

 

37,426

 

-

 

-

 

 

 

 

 

 

 

 

Investments in subsidiaries

-

 

-

 

2,017,373

 

2,017,373

Total non-current assets

1,749,416

 

1,752,579

 

2,017,373

 

2,017,373

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other receivables

667,637

 

366,425

 

1,845,027

 

1,450,431

 

 

 

 

 

 

 

 

Cash and cash equivalents

746,675

 

841,204

 

37,595

 

471,172

Total current assets

1,414,312

 

1,207,629

 

1,882,622

 

1,921,603

 

 

 

 

 

 

 

 

Current liabilities

Trade and other payables

(1,487,341)

(827,971)

(315,439)

(363,792)

Total current liabilities

(1,487,341)

(827,971)

(315,439)

(363,792)

 

 

 

 

 

 

 

Net current (liabilities)/assets

(73,030)

 

379,658

 

1,567,183

 

1,557,811

 

 

 

 

 

 

 

Net assets

1,676,387

 

2,132,237

 

3,584,556

 

3,575,184

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Called up share capital

1,531,315

 

1,531,315

 

1,531,315

 

1,531,315

 

 

 

 

 

 

 

 

Share premium account

9,428,169

 

9,428,169

 

9,428,169

 

9,428,169

 

 

 

 

 

 

 

 

Share option reserve

190,760

 

145,538

 

190,760

 

145,538

 

 

 

 

 

 

 

 

Retained earnings

(9,473,857)

 

(8,972,785)

 

(7,565,688)

 

(7,529,838)

 

1,676,387

2,132,237

 

3,584,556

 

3,575,184

 

Group Cash Flow Statement

 

For the year ended 30 June 2012

 

 

2012

 

2011

 

 

£

 

£

 

 

 

 

 

 

Net cash used in operating activities

(90,351)

 

(747,493)

 

 

Investing activities

 

 

 

 

 

 

 

 

 

Interest received

8,756

 

13,134

 

 

 

 

 

 

Purchases of plant and equipment

(12,934)

 

(11,214)

 

 

 

 

 

 

Disposal of plant and equipment

-

 

401

 

 

Net cash (used)/received in investing activities

(4,178)

 

2,321

 

 

Net decrease in cash and cash equivalents

(94,529)

 

(745,172)

 

 

 

 

 

 

Cash and cash equivalents at beginning of year

841,204

 

1,586,376

 

 

Cash and cash equivalents at end of year

746,675

 

841,204

 

 

 

Company Cash Flow Statement

 

For the year ended 30 June 2012

 

 

2012

 

2011

 

 

£

 

£

 

 

Net cash used in operating activities

(435,926)

 

(395,785)

 

 

Investing activities

 

 

 

 

 

 

 

 

 

Interest received

2,349

 

7,579

 

 

Net cash generated from investing activities

2,349

 

7,579

 

 

Net decrease in cash and cash equivalents

(433,577)

 

(388,206)

 

 

 

 

 

 

Cash and cash equivalents at beginning of year

471,172

 

859,378

 

 

Cash and cash equivalents at end of year

37,595

 

471,172

 

 

 

Notes to the Financial Statements

 

For the year ended 30 June 2012

 

1. Accounting policies

 

The principal accounting policies are summarised below. They have all been applied consistently throughout the period covered bythese financial statements.

 

Reporting entity

 

Arcontech Group PLC ("the Company") is a company incorporated in the United Kingdom. The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries (together referred to as "the Group").

 

Basis ofpreparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") endorsed by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

On the basis of current projections, confidence of future profitability and cash balances held, the Directors have adopted the going concern basis in the preparation of the financial statements.

 

The financial statements have been prepared under the historical cost convention.

 

2. Revenue

 

An analysis of the Group's revenue is as follows:

 

 

 

2012£

 

2011£

 

 

 

 

 

 

 

Financial information service, advertising and sponsorship, software development and consultancy

 

1,463,530

 

1,287,409

 

 

All of the Group's revenue relates to continuing activities.

 

3. Operating loss for the year is stated after charging:

 

 

 

2012£

 

2011£

 

Depreciation of plant and equipment

 

15,552

 

16,893

 

Loss on disposal of fixed assets

 

545

 

3,091

 

Staff costs (see note 7)

 

1,408,153

 

1,473,442

 

Operating lease rentals - land and buildings (see note 21)

 

79,000

 

73,075

 

Research and development

 

669,400

 

812,559

 

 

 

4. Loss per share

 

 

 

2012

 

2011

 

 

 

£

 

£

 

Earnings

 

 

 

 

 

Earnings for the purpose of basic and diluted earnings per share being net loss attributable to equity shareholders

 

(501,072)

 

(672,038)

 

 

 

(501,072)

 

(672,038)

 

 

 

 

No.

 

No.

 

Number of shares

 

 

 

 

 

Weighted average number of ordinary shares for the purpose of basic earnings per share

 

1,531,314,870

 

1,531,314,870

 

 

 

 

 

 

 

Number of dilutive shares under option

 

-

 

-

 

Weighted average number of ordinary shares for the purposes of dilutive earnings per share

 

1,531,314,870

 

1,531,314,870

 

 

The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options. A calculation is done to determine the number of shares that could have been acquired at fair value, based upon the monetary value of the subscription rights attached to outstanding share options. Share options are anti-dilutive and are therefore not included above.

 

5. Dividends

 

There were no dividends paid or proposed during the period (2011: £Nil).

 

6. Post balance sheet events

 

There were no events since the balance sheet date, which materially affect the position of the Group.

 

7. Annual General Meeting

 

The annual general meeting of the Company will be held at the Company's offices 8th Floor, Finsbury Tower, 103-105 Bunhill Row, London EC1Y 8LZ on 23 October 2012 at 10 a.m.

 

8. Annual Report & Accounts

 

Copies of the Annual Report & Accounts will be sent to shareholders shortly and are available from the Company Secretary at the Company's registered office at 8th Floor Finsbury Tower, 103-105 Bunhill Row, London, EC1Y 8LZ or from the Company's website at www.arcontech.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UGUWPRUPPGQP
Date   Source Headline
27th Sep 20175:23 pmRNSResult of AGM
26th Sep 201711:48 amRNSResult of AGM and Dividend Timetable
22nd Sep 20177:00 amRNSIssue of Equity
25th Aug 20179:20 amRNSPosting of Annual Report & Notice of AGM
24th Aug 201712:28 pmRNSHolding(s) in Company
17th Aug 201711:06 amRNSIssue of Equity & Director/PDMR Shareholding
14th Aug 20177:00 amRNSFinal Results
26th Jul 201711:08 amRNSIssue of Equity
6th Jul 20171:30 pmRNSIssue of Equity
3rd Jul 20174:09 pmRNSIssue of Equity
26th Jun 20171:42 pmRNSDirector Declaration
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
12th Jun 20174:29 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSIssue of Equity
10th May 20174:01 pmRNSDirector/PDMR Shareholding
8th May 20179:47 amRNSIssue of Equity & Director/PDMR Shareholding
4th May 20177:00 amRNSDirector/PDMR Shareholding
26th Apr 20177:00 amRNSGrant of Options and Director/PDMR Shareholdings
9th Mar 20176:05 pmRNSGrant of Options / Director Shareholding
6th Mar 20177:00 amRNSHalf-year Report
9th Dec 201612:22 pmRNSIssue of Equity
6th Dec 201610:06 amRNSHolding(s) in Company
2nd Dec 20167:00 amRNSAdditional Client Agreements
10th Nov 20167:00 amRNSDirector Dealing
21st Oct 20167:00 amRNSOpen-MAMA Steering Committee Membership
19th Oct 20163:00 pmRNSHolding(s) in Company
27th Sep 20161:58 pmRNSResult of AGM and Share Consolidation
23rd Sep 20167:00 amRNSExpanded Agreement with Client
1st Sep 20164:13 pmRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSAnnual Report, Notice of AGM & Share Consolidation
18th Aug 201610:59 amRNSDirector/PDMR Shareholding
18th Aug 20167:00 amRNSExtended Agreement with Client
16th Aug 201610:51 amRNSIssue of Equity
10th Aug 20167:00 amRNSFinal Results
26th May 20165:00 pmRNSDirector/PDMR Shareholding
17th Mar 20164:07 pmRNSDirector Share Transfer
17th Mar 20168:57 amRNSCancellation of Share Premium Account
10th Mar 201611:15 amRNSHolding(s) in Company
24th Feb 20167:00 amRNSHalf Yearly Report
26th Jan 201611:00 amRNSResult of AGM
11th Dec 20157:00 amRNSNotice of AGM
29th Sep 201511:20 amRNSResult of AGM
23rd Sep 20154:37 pmRNSForm 8.3 - Arcontech Group PLC
23rd Sep 20157:00 amRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSFinal Results
4th Jun 201510:45 amRNSUpdate re: Contract Termination
27th Apr 201511:08 amRNSHolding(s) in Company
2nd Apr 20157:00 amRNSMajor New Client Win
26th Mar 20157:00 amRNSChange of Adviser
26th Mar 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.